Renal activity of Akt kinase in obese zucker rats

Jana Ždychová, Ludmila Kazdová, Terezie Pelikanová, Jessie N. Lindsley, Sharon Anderson, Radko Komers

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Insulin resistance (IR) and consequent hyperinsulinemia are hallmarks of Type 2 diabetes (DM2). Akt kinase (Akt) is an important molecule in insulin signaling, implicated in regulation of glucose uptake, cell growth, cell survival, protein synthesis, and endothelial nitric oxide (NO) production. Impaired Akt activation in insulin-sensitive tissues contributes to IR. However, Akt activity in other tissues, particularly those affected by complications of DM2, has been less studied. We hypothesized that hyperinsulinemia could have an impact on activity of Akt and its effectors involved in regulation of renal morphology and function in DM2. To address this issue, renal cortical Akt was determined in obese Zucker rats (ZO), a model of DM2, and lean controls (ZL). We also studied expression and phosphorylation of the mammalian target of rapamycin (mTOR) and endothelial NO synthase (eNOS), molecules downstream of Akt in the insulin signaling cascade, and documented modulators of renal injury. Akt activity was measured by a kinase assay with GSK-3 as a substrate. Expression of phosphorylated (active) and total proteins was measured by immunoblotting and immunohistochemistry. Renal Akt activity was increased in ZO as compared to ZL rats, in parallel with progressive hyperinsulinemia. No differences in Akt were observed in the skeletal muscle. Corresponding to increases in Akt activity, ZO rats demonstrated enhanced phosphorylation of renal mTOR. Acute PI3K inhibition with wortmannin (100 μg/kg) attenuated renal Akt and mTOR activities in ZO, but not in ZL rats. In contrast to mTOR, eNOS phosphorylation was similar in ZO and ZL rats, despite higher total eNOS expression. In conclusion, ZO rats demonstrated increases in renal Akt and mTOR activity and expression. However, eNOS phosphorylation did not follow this pattern. These data suggest that DM2 is associated with selective IR in the kidney, allowing pro-growth signaling via mTOR, whereas potentially protective effects mediated by eNOS are blunted.

Original languageEnglish (US)
Pages (from-to)1231-1241
Number of pages11
JournalExperimental Biology and Medicine
Volume233
Issue number10
DOIs
StatePublished - Oct 2008

Fingerprint

Zucker Rats
Sirolimus
Rats
Phosphorylation
Phosphotransferases
Insulin
Kidney
Nitric Oxide Synthase
Hyperinsulinism
Insulin Resistance
Tissue
Glycogen Synthase Kinase 3
Molecules
Nitric Oxide Synthase Type III
Cell growth
Medical problems
Phosphatidylinositol 3-Kinases
Modulators
Muscle
Assays

Keywords

  • Akt kinase
  • Endothelial nitric oxide synthase
  • Mammalian target of rapamycin
  • MTOR
  • Phosphatidylinositol 3-kinase
  • Zucker rat

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ždychová, J., Kazdová, L., Pelikanová, T., Lindsley, J. N., Anderson, S., & Komers, R. (2008). Renal activity of Akt kinase in obese zucker rats. Experimental Biology and Medicine, 233(10), 1231-1241. https://doi.org/10.3181/0801-RM-29

Renal activity of Akt kinase in obese zucker rats. / Ždychová, Jana; Kazdová, Ludmila; Pelikanová, Terezie; Lindsley, Jessie N.; Anderson, Sharon; Komers, Radko.

In: Experimental Biology and Medicine, Vol. 233, No. 10, 10.2008, p. 1231-1241.

Research output: Contribution to journalArticle

Ždychová, J, Kazdová, L, Pelikanová, T, Lindsley, JN, Anderson, S & Komers, R 2008, 'Renal activity of Akt kinase in obese zucker rats', Experimental Biology and Medicine, vol. 233, no. 10, pp. 1231-1241. https://doi.org/10.3181/0801-RM-29
Ždychová J, Kazdová L, Pelikanová T, Lindsley JN, Anderson S, Komers R. Renal activity of Akt kinase in obese zucker rats. Experimental Biology and Medicine. 2008 Oct;233(10):1231-1241. https://doi.org/10.3181/0801-RM-29
Ždychová, Jana ; Kazdová, Ludmila ; Pelikanová, Terezie ; Lindsley, Jessie N. ; Anderson, Sharon ; Komers, Radko. / Renal activity of Akt kinase in obese zucker rats. In: Experimental Biology and Medicine. 2008 ; Vol. 233, No. 10. pp. 1231-1241.
@article{7b235ba2d76f4152832e1e75e577a734,
title = "Renal activity of Akt kinase in obese zucker rats",
abstract = "Insulin resistance (IR) and consequent hyperinsulinemia are hallmarks of Type 2 diabetes (DM2). Akt kinase (Akt) is an important molecule in insulin signaling, implicated in regulation of glucose uptake, cell growth, cell survival, protein synthesis, and endothelial nitric oxide (NO) production. Impaired Akt activation in insulin-sensitive tissues contributes to IR. However, Akt activity in other tissues, particularly those affected by complications of DM2, has been less studied. We hypothesized that hyperinsulinemia could have an impact on activity of Akt and its effectors involved in regulation of renal morphology and function in DM2. To address this issue, renal cortical Akt was determined in obese Zucker rats (ZO), a model of DM2, and lean controls (ZL). We also studied expression and phosphorylation of the mammalian target of rapamycin (mTOR) and endothelial NO synthase (eNOS), molecules downstream of Akt in the insulin signaling cascade, and documented modulators of renal injury. Akt activity was measured by a kinase assay with GSK-3 as a substrate. Expression of phosphorylated (active) and total proteins was measured by immunoblotting and immunohistochemistry. Renal Akt activity was increased in ZO as compared to ZL rats, in parallel with progressive hyperinsulinemia. No differences in Akt were observed in the skeletal muscle. Corresponding to increases in Akt activity, ZO rats demonstrated enhanced phosphorylation of renal mTOR. Acute PI3K inhibition with wortmannin (100 μg/kg) attenuated renal Akt and mTOR activities in ZO, but not in ZL rats. In contrast to mTOR, eNOS phosphorylation was similar in ZO and ZL rats, despite higher total eNOS expression. In conclusion, ZO rats demonstrated increases in renal Akt and mTOR activity and expression. However, eNOS phosphorylation did not follow this pattern. These data suggest that DM2 is associated with selective IR in the kidney, allowing pro-growth signaling via mTOR, whereas potentially protective effects mediated by eNOS are blunted.",
keywords = "Akt kinase, Endothelial nitric oxide synthase, Mammalian target of rapamycin, MTOR, Phosphatidylinositol 3-kinase, Zucker rat",
author = "Jana Ždychov{\'a} and Ludmila Kazdov{\'a} and Terezie Pelikanov{\'a} and Lindsley, {Jessie N.} and Sharon Anderson and Radko Komers",
year = "2008",
month = "10",
doi = "10.3181/0801-RM-29",
language = "English (US)",
volume = "233",
pages = "1231--1241",
journal = "Experimental Biology and Medicine",
issn = "1535-3702",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - Renal activity of Akt kinase in obese zucker rats

AU - Ždychová, Jana

AU - Kazdová, Ludmila

AU - Pelikanová, Terezie

AU - Lindsley, Jessie N.

AU - Anderson, Sharon

AU - Komers, Radko

PY - 2008/10

Y1 - 2008/10

N2 - Insulin resistance (IR) and consequent hyperinsulinemia are hallmarks of Type 2 diabetes (DM2). Akt kinase (Akt) is an important molecule in insulin signaling, implicated in regulation of glucose uptake, cell growth, cell survival, protein synthesis, and endothelial nitric oxide (NO) production. Impaired Akt activation in insulin-sensitive tissues contributes to IR. However, Akt activity in other tissues, particularly those affected by complications of DM2, has been less studied. We hypothesized that hyperinsulinemia could have an impact on activity of Akt and its effectors involved in regulation of renal morphology and function in DM2. To address this issue, renal cortical Akt was determined in obese Zucker rats (ZO), a model of DM2, and lean controls (ZL). We also studied expression and phosphorylation of the mammalian target of rapamycin (mTOR) and endothelial NO synthase (eNOS), molecules downstream of Akt in the insulin signaling cascade, and documented modulators of renal injury. Akt activity was measured by a kinase assay with GSK-3 as a substrate. Expression of phosphorylated (active) and total proteins was measured by immunoblotting and immunohistochemistry. Renal Akt activity was increased in ZO as compared to ZL rats, in parallel with progressive hyperinsulinemia. No differences in Akt were observed in the skeletal muscle. Corresponding to increases in Akt activity, ZO rats demonstrated enhanced phosphorylation of renal mTOR. Acute PI3K inhibition with wortmannin (100 μg/kg) attenuated renal Akt and mTOR activities in ZO, but not in ZL rats. In contrast to mTOR, eNOS phosphorylation was similar in ZO and ZL rats, despite higher total eNOS expression. In conclusion, ZO rats demonstrated increases in renal Akt and mTOR activity and expression. However, eNOS phosphorylation did not follow this pattern. These data suggest that DM2 is associated with selective IR in the kidney, allowing pro-growth signaling via mTOR, whereas potentially protective effects mediated by eNOS are blunted.

AB - Insulin resistance (IR) and consequent hyperinsulinemia are hallmarks of Type 2 diabetes (DM2). Akt kinase (Akt) is an important molecule in insulin signaling, implicated in regulation of glucose uptake, cell growth, cell survival, protein synthesis, and endothelial nitric oxide (NO) production. Impaired Akt activation in insulin-sensitive tissues contributes to IR. However, Akt activity in other tissues, particularly those affected by complications of DM2, has been less studied. We hypothesized that hyperinsulinemia could have an impact on activity of Akt and its effectors involved in regulation of renal morphology and function in DM2. To address this issue, renal cortical Akt was determined in obese Zucker rats (ZO), a model of DM2, and lean controls (ZL). We also studied expression and phosphorylation of the mammalian target of rapamycin (mTOR) and endothelial NO synthase (eNOS), molecules downstream of Akt in the insulin signaling cascade, and documented modulators of renal injury. Akt activity was measured by a kinase assay with GSK-3 as a substrate. Expression of phosphorylated (active) and total proteins was measured by immunoblotting and immunohistochemistry. Renal Akt activity was increased in ZO as compared to ZL rats, in parallel with progressive hyperinsulinemia. No differences in Akt were observed in the skeletal muscle. Corresponding to increases in Akt activity, ZO rats demonstrated enhanced phosphorylation of renal mTOR. Acute PI3K inhibition with wortmannin (100 μg/kg) attenuated renal Akt and mTOR activities in ZO, but not in ZL rats. In contrast to mTOR, eNOS phosphorylation was similar in ZO and ZL rats, despite higher total eNOS expression. In conclusion, ZO rats demonstrated increases in renal Akt and mTOR activity and expression. However, eNOS phosphorylation did not follow this pattern. These data suggest that DM2 is associated with selective IR in the kidney, allowing pro-growth signaling via mTOR, whereas potentially protective effects mediated by eNOS are blunted.

KW - Akt kinase

KW - Endothelial nitric oxide synthase

KW - Mammalian target of rapamycin

KW - MTOR

KW - Phosphatidylinositol 3-kinase

KW - Zucker rat

UR - http://www.scopus.com/inward/record.url?scp=54549121664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54549121664&partnerID=8YFLogxK

U2 - 10.3181/0801-RM-29

DO - 10.3181/0801-RM-29

M3 - Article

VL - 233

SP - 1231

EP - 1241

JO - Experimental Biology and Medicine

JF - Experimental Biology and Medicine

SN - 1535-3702

IS - 10

ER -